✦ LIBER ✦

Dosing patterns and costs of erythropoietic agents in patients with chronic kidney disease not on dialysis in managed care organizations

✍ Scribed by Mei Sheng Duh; Samir H. Mody; R. Scott McKenzie; Patrick Lefebvre; Antoine Gosselin; Catherine Tak Piech

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

147: Drug Utilization and Cost Considera

✍ Samir Mody; Francis Vekeman; Antoine Gosselin; Brahim Bookhart; R. Scott McKenzi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 191 KB

140: Assessment of Drug Utilization Patt

✍ Patrick Lefebvre; François Laliberté; Marie-Héléne Lafeuille; Brahim Bookhart; R 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 196 KB

PUK15 DRUG UTILIZATION AND COSTS OF ERYT

✍ P Lefebvre; MS Duh; F Laliberte; RS Mckenzie; S Mody; B Bookhart; CT Piech 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

DU6 ASSESSMENT OF DRUG UTILIZATION PATTE

✍ MH Lafeuille; P Lefebvre; B Bookhart; F Laliberte; R Bailey; M Corral; CT Piech 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

159 Assessment of Recent Erythropoiesis-

✍ Marie-Hélène Lafeuille; Natalia Mishagina; Robert A. Bailey; Mekré Senbetta; Pat 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 201 KB

108: Drug Utilization and Costs for Eryt

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 116 KB